PMVP Stock Price | Pmv Pharmaceuticals Inc P/E, Revenue, EPS, & Forecasts

Pmv Pharmaceuticals Inc • PMVP

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Pmv Pharmaceuticals Inc

Ticker

PMVP

Trading on

NASDAQ

ISIN

US69353Y1038

Industry

Biotechnology

Sector

Healthcare

CEO

Dr. David H. Mack Ph.D.

Headquarters

400 Alexander Park Drive, Princeton, NJ, United States, 08540

Employees

Website

pmvpharma.com

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.

Metrics

BasicAdvanced

Market cap

$68.6M

P/E ratio

EPS

-$1.59

Dividend Yield

0.00%

Beta

1.64

Forward P/E ratio

EBIDTA

$-91.4M

Ex dividend date

Price & volume

Market cap

$68.6M

Average daily volume

0.3M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

0.54

Earnings

EPS

-$1.59

EPS estimate (current quarter)

-$0.40

EPS estimate (next quarter)

-$0.42

EBITDA

$-91.4M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

1.64

52-week High

$1.84

52-week Low

$0.81

50-day moving average

$1.40

200-day moving average

$1.25

Short ratio

2.57

Short %

3.40%

Management effectiveness

ROE (TTM)

-51.87%

ROA (TTM)

-32.02%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

53.2M

Float

41.1M

Insiders %

3.30%

Institutions %

70.21%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 5 analysts.

Average price target

$7.60

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.45

-$0.38

-18.42%

Q4 • 24Missed

-$0.34

-$0.38

11.30%

Q1 • 25Beat

-$0.41

-$0.39

-5.13%

Q2 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-21.2M

-∞%

Q2 • 25

$0M

$-21.1M

-∞%

Q3 • 25

NaN%

-0.71%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$153M

$12.3M

8.01%

Q2 • 25

$134M

$12.8M

9.60%

Q3 • 25

-12.44%

4.86%

19.75%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-18.3M

$11M

$0.1M

$-18.3M

Q2 • 25

$-19.8M

$12M

$0M

$-19.8M

Q3 • 25

8.29%

9.48%

-100.00%

8.22%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Pmv Pharmaceuticals Inc share?

Pmv Pharmaceuticals Inc shares are currently traded for undefined per share.

How many shares does Pmv Pharmaceuticals Inc have?

Pmv Pharmaceuticals Inc currently has 53.2M shares.

Does Pmv Pharmaceuticals Inc pay dividends?

No, Pmv Pharmaceuticals Inc doesn't pay dividends.

What is Pmv Pharmaceuticals Inc 52 week high?

Pmv Pharmaceuticals Inc 52 week high is $1.84.

What is Pmv Pharmaceuticals Inc 52 week low?

Pmv Pharmaceuticals Inc 52 week low is $0.81.

What is the 200-day moving average of Pmv Pharmaceuticals Inc?

Pmv Pharmaceuticals Inc 200-day moving average is $1.25.

Who is Pmv Pharmaceuticals Inc CEO?

The CEO of Pmv Pharmaceuticals Inc is Dr. David H. Mack Ph.D..

How many employees Pmv Pharmaceuticals Inc has?

Pmv Pharmaceuticals Inc has 47 employees.

What is the market cap of Pmv Pharmaceuticals Inc?

The market cap of Pmv Pharmaceuticals Inc is $68.6M.

What is the P/E of Pmv Pharmaceuticals Inc?

The current P/E of Pmv Pharmaceuticals Inc is null.

What is the EPS of Pmv Pharmaceuticals Inc?

The EPS of Pmv Pharmaceuticals Inc is -$1.59.

What is the PEG Ratio of Pmv Pharmaceuticals Inc?

The PEG Ratio of Pmv Pharmaceuticals Inc is null.

What do analysts say about Pmv Pharmaceuticals Inc?

According to the analysts Pmv Pharmaceuticals Inc is considered a buy.